Honma, Naoko
Yoshida, Masayuki
Kinowaki, Keiichi
Horii, Rie
Katsurada, Yuka
Murata, Yuya
Shimizu, Ai
Tanabe, Yuko
Yamauchi, Chikako
Yamamoto, Yutaka
Iwata, Hiroji
Saji, Shigehira
Article History
Received: 25 September 2023
Accepted: 18 October 2023
First Online: 7 November 2023
Declarations
:
: Naoko Honma: Payment or honoraria for lectures (personal), Daiichi-Sankyo, Pfizer; Participation on an advisory board, Roche Diagnostics. Masayuki Yoshida: Consulting fees, Lilly Japan, Roche Diagnostics; Payment or honoraria for lectures (personal), Agillent technologies, Chugai, MSD, Ono, Daiichi-Sankyo; Rie Horii: Grants or contracts (institution), Roche Diagnostics; Payment or honoraria for lectures and manuscript writing or educational events (personal), Chugai, MSD, US-Lead, Roche Diagnostics, Daiichi-Sankyo, Pfizer, Astra Zeneca, Medical View, Bunkodo, Shinoharashinsha Publishing, Ishiyaku Publishers, Nakayama Shoten, Nanzando, Elsevier Japan; Participation on a data safety monitoring board or advisory board, Chugai, Daiichi-Sankyo, Roche Diagnostics. Yutaka Yamamoto: Grants or contracts (institution), Chugai, Kyowa kirin, Eisai, Daiichi-Sankyo, Nippon-Kayaku, Taiho, Takeda, Lilly, Pfizer, Novartis; Payment or honoraria for lectures (personal), Astra Zeneca, Chugai, Kyowa-kirin, Novartis, Lilly, Pfizer, Daiichi-Sankyo, Nippon-kayaku; MSD, Eisai, Takeda, Taiho, Sysmex, Exact Science; Participation on a data safety monitoring board or advisory board, Chugai, Astra Zeneca, Novartis, Lilly, Pfizer, Daiichi-Sankyo, MSD; Other financial or non-financial interests (member of the board of directors), Japanese Brest Cancer Society, Japan Breast Cancer Research Group. Hiroji Iwata: Grants or contracts (institution), Chugai, Daiichi Sankyo; Astra Zeneca; Payment or honoraria for lectures (personal), Daiichi Sankyo, Chugai, Astra Zeneca, Lilly, MSD, Pfizer, Taiho, Kyowa Kirin. Shigehira Saji: Grants or contracts (institution), Taiho, Eisai, Chugai, Takeda, MSD, Astra Zeneca, Daiichi Sankyo; Payment or honoraria for lectures (personal), Chugai, Kyowa kirin, MSD, Novartis, Eisai, Takeda, Daiichi Sankyo, Eli Lilly, Astra Zeneca, Pfizer, Taiho, Ono, Nippon kayaku; Participation on a data safety monitoring board or advisory board (personal), Chugai/Roche, Astra Zeneca, Eli Lilly, Pfizer, Kyowa Kirin, Daiichi Sankyo, MSD; Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid (executive board member), JBCRG, JBCS, JSMO, BIG.